Our Team

Matt has been a healthcare-focused venture capital investor since 1980. He began his venture capital career with Citicorp Venture Capital, where he was VP and a member of the investment executive committee. Matt later joined Robertson, Stephens & Co. and was partner and Chairman of the Venture Capital Group. In 1991 he formed Mackowski & Shepler, an investment partnership focused on developing life science and medical technology companies and the predecessor to THP. Matt has represented THP on the boards of Kinetikos Medical (acquired by Integra), Ambion (acquired by Applied Biosystems), Aurora Discovery (acquired by NEXUS Biosystems), Interface Associates (acquired by NDC), Asuragen, Althea Technologies (acquired by Ajinomoto), AltheaDx, MedPricer, Magstim and TrakCel. Matt received a BA from Duke University and an MBA from The Wharton School.

Mike is an accomplished executive with over 25 years of broad-based managerial and financial experience in the healthcare industry, including expertise building high growth, dynamic companies. Mike began his career with PricewaterhouseCoopers where he spent 12 years prior to joining Sachs Group, a healthcare data and information company, as its chief financial officer (CFO). Upon the sale of Sachs Group, Mike again partnered with Michael Sachs to form Sg2, a healthcare analytics and intelligence company where Mike served as executive vice president and CFO until the Sg2 sale in 2014. Mike is currently vice chairman and CFO of TLSG Investments, LLC, an early-stage venture firm focused on technology-enabled healthcare services and SAAS-based software companies. He serves on several boards of TLSG Investments’ portfolio companies. Mike is a Certified Public Accountant and holds a Bachelor of Science in Accounting from Northern Illinois University.

Rob is a highly experienced strategist and executive, and is part of the team at Telegraph Hill Partners. Previously, Rob was a Partner at Trinity Life Sciences, a consultancy focused on evidence-based clinical and commercial development strategy across therapeutics, diagnostics, and medical technology sectors. Rob also spent 10 years as a strategy consultant working with emerging biotechnology & medical technology companies as well as large, global organizations to inform key decisions on clinical development, launch strategy, market development, brand lifecycle strategy, and promotional campaign development. Rob’s other roles include having worked as an Associate at Telegraph Hill Partners, and in investment banking focusing on life sciences and technology verticals. Rob graduated from the University of Notre Dame with a BBA in Finance, and received an MBA with honors from UC Berkeley’s Haas School of Business.

Gary has worked in the healthcare and medical device industry since 1981. Gary began his career in healthcare with United States Surgical Corporation where he spent 22 years in roles of increasing responsibilities, including Vice President of Sales Operations and Distribution Sales for Tyco Healthcare following the acquisition of USS by Kendall. He next joined UTI Corporation as Executive Vice President of Sales and Marketing, where he led the sales and marketing strategy through the acquisition and integration of MedSource Technologies, the re-branding of the combined organization as Accellent, and its acquisition by Kohlberg, Kravis, and Roberts in 2005. Gary then joined Telegraph Hill Partner (THP) portfolio company Interface Catheter Solutions as President and CEO. He led the strategic growth into contract manufacturing through its acquisition by NDC/Confluent Medical in 2015. Most recently, Gary was President of Trelyst, a subsidiary of NuSil Technology LLC focused on developing silicone-based combination drug-delivery devices and through its merger with Avantor in 2016. Gary has represented THP on the boards of Argonaut Manufacturing Services, Dynex Technologies, InvisALERT and Medpricer (acquired by Premier). Gary holds a Bachelor of Science in Marketing from Millikin University.

Larry Kocot is a respected business strategist and healthcare industry expert and has been working in the healthcare industry for over three decades. Kocot is a renowned expert on regulatory and policy trends driving healthcare transformation, industry convergence, and the evolution of payment and delivery. Kocot recently retired from KPMG LLP, where he was a Principal in the Advisory practice and National Leader of the Center for Healthcare Regulatory Insight. Prior to KPMG, Kocot was a Visiting Fellow pf the Economic Studies Program at the Brookings Institution, and Senior Counsel at Epstein Becker Green, PC. Larry served as Senior Advisor to the Administrator at the Centers for Medicare & Medicaid Services (CMS) at the Department of Health and Human Services for the implementation of Medicare Part D, where he was a key member of the management and operations team. Prior to his government service, Larry was Senior Vice President and General Counsel at the National Association of Chain Store Drug Stores. Kocot has served on a number of public and private boards. In addition to the ETS board, he currently serves as Board of Director of WPS Health Solutions and is a member of Virginia Board of Pharmacy. Larry holds a Bachelor of Arts (B.A.) and Master of Public Administration (M.P.A) degrees from the University of Amherst. He earned both his Juris Doctor (J.D.) and Master of Laws (LL.M.) in International and Comparative Law from Georgetown University Law Center. 

Dave is a veteran of the health care industry and is a seasoned CEO and founder. Prior to co-founding Emerging Therapy Solutions, Dave led several managed care technology companies, including Medication Management Systems, Inc. (acquired by Genoa HealthCare), NovoLogix (acquired by CVS), and RxHub. Previously, Dave was CEO of United Resource Networks at United Health Group, a business that managed organ and tissue transplants for 45 million payer lives, and SVP at American MedCenters, and HMO management company. Dave holds a BS in Pharmacy from Ohio State University and a Ph.D. from the University of Minnesota.

Ravi is a seasoned executive and founder with a strong background in finance and healthcare and clinical services. Prior to TrakCel, Ravi was the CFO of Biotec Services International and has extensive leadership experience in finance, health, biotech, safety, and environmental functions. Ravi has a BSc in Biochemistry and Molecular Biology from Cardiff University.

Kevin has extensive knowledge and experience in health care and health care transactions. His primary goal is to help small and medium sized health care companies grow successfully and maximize their value. Kevin has a law degree and an MBA from the University of Minnesota. His experience spans law, healthcare, and mergers and acquisitions, having participated in over 70 transactions.